This vertically integrated pharmaceutical company specializes in developing, manufacturing, and marketing a wide range of products across multiple therapeutic areas. Their key focus areas include oncology, blood-related products, nephrology, cardiology, gynecology, diabetology, and beta-lactam cephalosporins, along with vitamins and minerals. They also offer nutraceuticals and herbal products. The company's product portfolio encompasses various dosage forms such as injectables, suppositories, tablets, capsules, suspensions, syrups, ointments, emulsions, elixirs, ophthalmics, effervescent tablets, and dry powder. They have a strong global presence, participating in prominent industry events across regions like Europe and the Middle East. The company prioritizes quality and adheres to GMP certifications, further bolstering their commitment to delivering reliable pharmaceutical solutions.

Established in 2018, this manufacturer specializes in oncology, anti-cancer, cytotoxic, critical-care, life-saving, and general injectables, as well as oral solids like tablets and capsules. As a CTD dossier owner and manufacturer, it exports products to over 30 countries across Asia, Africa, LATAM, CIS, MENA, and Europe. Operating under WHO-GMP and PIC/S certifications, the GMP manufacturer maintains advanced production lines for liquid injectables, lyophilized injectables, pre-filled syringes, tablets, and capsules. As a CTD dossier owner and manufacturer, it upholds stringent quality standards and regulatory compliance